1. Home
  2. FULC vs TCX Comparison

FULC vs TCX Comparison

Compare FULC & TCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • TCX
  • Stock Information
  • Founded
  • FULC 2015
  • TCX 1992
  • Country
  • FULC United States
  • TCX Canada
  • Employees
  • FULC N/A
  • TCX N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • TCX EDP Services
  • Sector
  • FULC Health Care
  • TCX Technology
  • Exchange
  • FULC Nasdaq
  • TCX Nasdaq
  • Market Cap
  • FULC 221.5M
  • TCX 179.0M
  • IPO Year
  • FULC 2019
  • TCX 1996
  • Fundamental
  • Price
  • FULC $3.64
  • TCX $16.04
  • Analyst Decision
  • FULC Hold
  • TCX
  • Analyst Count
  • FULC 10
  • TCX 0
  • Target Price
  • FULC $7.44
  • TCX N/A
  • AVG Volume (30 Days)
  • FULC 676.6K
  • TCX 35.6K
  • Earning Date
  • FULC 11-13-2024
  • TCX 11-07-2024
  • Dividend Yield
  • FULC N/A
  • TCX N/A
  • EPS Growth
  • FULC N/A
  • TCX N/A
  • EPS
  • FULC N/A
  • TCX N/A
  • Revenue
  • FULC $81,630,000.00
  • TCX $356,135,000.00
  • Revenue This Year
  • FULC $2,821.96
  • TCX $8.16
  • Revenue Next Year
  • FULC N/A
  • TCX N/A
  • P/E Ratio
  • FULC N/A
  • TCX N/A
  • Revenue Growth
  • FULC 2582.55
  • TCX 7.50
  • 52 Week Low
  • FULC $2.87
  • TCX $15.78
  • 52 Week High
  • FULC $13.70
  • TCX $28.66
  • Technical
  • Relative Strength Index (RSI)
  • FULC 50.49
  • TCX 34.39
  • Support Level
  • FULC $3.38
  • TCX $15.78
  • Resistance Level
  • FULC $3.63
  • TCX $18.98
  • Average True Range (ATR)
  • FULC 0.16
  • TCX 0.83
  • MACD
  • FULC 0.12
  • TCX -0.18
  • Stochastic Oscillator
  • FULC 87.18
  • TCX 27.36

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About TCX Tucows Inc.

Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains.

Share on Social Networks: